We have recently demonstrated that obesity results in increased expression of PD-1 on T cells, and checkpoint blockade targeting PD-1/PD-L1 surprisingly resulted in greater clinical efficacy in cancer therapy. The gene discussed is CD274; the disease is obesity due to melanocortin 4 receptor deficiency.